Does renal denervation provide safe and sustained blood pressure reductions and preserve kidney function in hypertensive patients?
Real-world data from the Global SYMPLICITY Registry indicates that renal denervation provides safe and sustained reductions in blood pressure up to 3 years in hypertensive patients.
Long-term data from the Global SYMPLICITY Registry representing the largest available cohort of hypertensive patients receiving RDN in a real-world clinical setting demonstrate both the safety and efficacy of the procedure with significant and sustained office and ambulatory BP reductions out to 3 years.
Mahfoud et al. (Wed,) studied this question.